Expression levels of AQP9 and SOCS3 in leukocytes demonstrated high diagnostic value for distinguishing acute myocardial infarction from stable coronary artery disease, with an AUC > 0.9.
Observational (n=260)
No
Does measurement of AQP9 and SOCS3 gene expression in leukocytes improve the diagnosis of acute myocardial infarction compared to stable coronary artery disease?
Leukocyte expression of AQP9 and SOCS3, identified via integrated machine learning, demonstrates high diagnostic accuracy for distinguishing acute myocardial infarction from stable coronary artery disease.
Effect estimate: AUC > 0.9
Abstract Background Acute myocardial infarction (AMI) has two clinical characteristics: high missed diagnosis and dysfunction of leukocytes. Transcriptional RNA on leukocytes is closely related to the course evolution of AMI patients. We hypothesized that transcriptional RNA in leukocytes might provide potential diagnostic value for AMI. Integration machine learning (IML) was first used to explore AMI discrimination genes. The following clinical study was performed to validate the results. Methods A total of four AMI microarrays (derived from the Gene Expression Omnibus) were included in this study (220 sample size), and the controls were identified as patients with stable coronary artery disease (SCAD). At a ratio of 5:2, GSE59867 was included in the training set, while GSE60993, GSE62646, and GSE48060 were included in the testing set. IML was explicitly proposed in this research, which is composed of six machine learning algorithms, including support vector machine (SVM), neural network (NN), random forest (RF), gradient boosting machine (GBM), decision trees (DT), and least absolute shrinkage and selection operator (LASSO). IML had two functions in this research: filtered optimized variables and predicted the categorized value. Furthermore, 40 individuals were recruited, and the results were verified. Results Thirty-nine differentially expressed genes (DEGs) were identified between controls and AMI individuals from the training sets. Among the thirty-nine DEGs, IML was used to process the predicted classification model and identify potential candidate genes with overall normalized weights >1. Finally, Two genes (AQP9 and SOCS3) show their diagnosis value with the area under the curve (AUC) > 0.9 in both the training and testing sets. The clinical study verified the significance of AQP9 and SOCS3. Notably, more stenotic coronary arteries or severe Killip classification indicated higher levels of these two genes, especially SOCS3. These two genes correlated with two immune cell types, monocytes and neutrophils. Conclusion AQP9 and SOCS3 in leukocytes may be conducive to identifying AMI patients with SCAD patients. AQP9 and SOCS3 are closely associated with monocytes and neutrophils, which might contribute to advancing AMI diagnosis and shed light on novel genetic markers. Multiple clinical characteristics, multicenter, and large-sample relevant trials are still needed to confirm its clinical value.
Zhang et al. (Fri,) conducted a observational in Acute Myocardial Infarction (n=260). AQP9 and SOCS3 gene expression in leukocytes vs. Stable coronary artery disease (SCAD) patients was evaluated on Diagnostic value (Area Under the Curve) for differentiating AMI from SCAD (AUC > 0.9). Expression levels of AQP9 and SOCS3 in leukocytes demonstrated high diagnostic value for distinguishing acute myocardial infarction from stable coronary artery disease, with an AUC > 0.9.